Benoit Champluvier

Head of Pharmaceutical Development • Sangamo Therapeutics

Benoit is a distinguished Bioprocess Development Director boasting over two decades of experience in the field. With an unwavering passion for advancing bioprocesses, he has been a driving force behind their design, development, GMP production, and quality control. His notable contributions have significantly impacted the industry, particularly in his instrumental role in the development and successful launch of several major vaccines during his tenure at GSK.

Transitioning his focus to cell therapy process development in 2016, Benoit’s expertise extends across various domains, including bioprocess and analytical method development, as well as the meticulous manufacturing of clinical lots under GMP regulations.

Throughout his career, Benoit has not only excelled in technical domains but has also showcased exceptional leadership skills. As a seasoned Director, he has adeptly managed multidisciplinary project teams and cultivated collaborations with multinational clients and colleagues. His leadership has been pivotal in driving operational excellence across complex matrix organizations, leading and guiding up to 150 individuals.

Benoit’s comprehensive industry knowledge, coupled with his leadership prowess, positions him as a prominent figure in the bioprocess and cell therapy sectors. His contributions have left a lasting impact on the development and success of critical medical advancements.

Also speaking

Laura Herbst

M. Sc. Research Fellow • Fraunhofer

Ruud Das

Chief Scientific Officer • Scinus Cell Expansion Netherlands B.V

Volker Huppert

Chief Development Officer • GlycoStem

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.